LDL-cholesterol levels and LDL polygenic score in a cohort of patients with clinically diagnosed familial hypercholesterolemia. Data from the lipigen study
Immune-inflammatory proteomics associated with elevated cardiovascular risk in genetically determined familial hypercholesterolemia
Modelling a two-stage screen for autosomal dominant familial hypercholesterolaemia (FH) in UK biobank
Universal screening is an effective strategy for detecting patients with familial hypercholesterolemia
Global perspective of paediatric familial hypercholesterolaemia: analysis from the EAS FHSC registry on over 11,200 children and adolescents with heterozygous familial hypercholesterolaemia from 44 countries
